BAIAP2L2 facilitates the malignancy of prostate cancer (PCa) via VEGF and apoptosis signaling pathways
- 1 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Genes & Genomics
- Vol. 43 (4), 421-432
- https://doi.org/10.1007/s13258-021-01061-8
Abstract
Background Prostate cancer (PCa) is the second most common type of male cancer in western. Despite key roles of brain-specific angiogenesis inhibitor 1-associated protein like 2 (BAIAP2L2) in several cancers, the function of BAIAP2L2 in PCa is never reported. Objective We aimed to investigate the role of BAIAP2L2 in the progression of PCa and decipher the underlying mechanisms. Methods RNA sequencing data from TCGA database were used to evaluate the expression of BAIAP2L2 in PCa. Survival analysis and Cox regression model analysis were conducted to evaluate the prognostic value of BAIAP2L2. BAIAP2L2-associated pathways were preliminary analyzed by Gene Set Enrichment Analysis (GSEA) method and confirmed by western blot assays. Cell proliferation and transwell assays were performed to determine biological behaviors in BAIAP2L2 knocked-down or overexpressed PCa cell lines including LNCaP and PC-3 cells. Results In our study, BAIAP2L2 was significantly up-regulated in PCa tissues and cell lines and independently associated with the poor prognosis of PCa patients. Knockdown of BAIAP2L2 notably repressed proliferation, migration and invasion of PCa cells. And overexpression of BAIAP2L2 obtained the contrary results. Mechanically, GSEA method and western blot results of key molecules in signaling pathways implicated that the depletion of BAIAP2L2 inactivated the vascular endothelial growth factors (VEGFs) and induced apoptosis signaling pathways in PCa cells. Conclusions Overall, these findings revealed that BAIAP2L2 may support tumorigenesis and malignant development of prostate cancer cells via VEGF and apoptosis signaling pathways, and it could be considered as a promising biomarker and independent prognostic predictor of prostate cancer.Keywords
This publication has 41 references indexed in Scilit:
- PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after RadiotherapyInternational Journal of Molecular Sciences, 2014
- Screening for Prostate Cancer With the Prostate-Specific Antigen TestJama-Journal Of The American Medical Association, 2014
- VEGF targets the tumour cellNature Reviews Cancer, 2013
- Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinomaCancer Letters, 2013
- The BAR Domain Superfamily Proteins from Subcellular Structures to Human DiseasesMembranes, 2012
- Pinkbar is an epithelial-specific BAR domain protein that generates planar membrane structuresNature Structural & Molecular Biology, 2011
- Downregulation of BCL-2 Induces Downregulation of Carbonic Anhydrase IX, Vascular Endothelial Growth Factor, and pAkt and Induces Radiation SensitizationUrology, 2007
- Lipoxygenase metabolism: roles in tumor progression and survivalCancer and Metastasis Reviews, 2007
- Structural basis of filopodia formation induced by the IRSp53/MIM homology domain of human IRSp53The EMBO Journal, 2005
- Factors Influencing Oral Mucositis in Patients Receiving ChemotherapyCancer Practice, 2000